GC4711 +SBRT
GTI-4711-101
Phase 2 small_molecule terminated
Quick answer
GC4711 +SBRT for SBRT is a Phase 2 program (small_molecule) at Galera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Galera Therapeutics
- Indication
- SBRT
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated